IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
24.63
-0.30 (-1.20%)
At close: Sep 12, 2025, 4:00 PM EDT
24.54
-0.09 (-0.35%)
After-hours: Sep 12, 2025, 5:45 PM EDT
IDEAYA Biosciences Stock Forecast
Stock Price Forecast
The 12 analysts that cover IDEAYA Biosciences stock have a consensus rating of "Buy" and an average price target of $47.75, which forecasts a 93.87% increase in the stock price over the next year. The lowest target is $27 and the highest is $74.
Price Target: $47.75 (+93.87%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IDEAYA Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 4 | 4 | 4 | 4 | 2 |
Buy | 7 | 7 | 8 | 8 | 8 | 11 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 13 | 12 | 13 | 13 | 13 | 14 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Mizuho | Mizuho | Buy Maintains $43 → $44 | Buy | Maintains | $43 → $44 | +78.64% | Sep 12, 2025 |
RBC Capital | RBC Capital | Buy Maintains $36 → $38 | Buy | Maintains | $36 → $38 | +54.28% | Sep 9, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 9, 2025 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $45 | Buy | Reiterates | $45 | +82.70% | Sep 9, 2025 |
JMP Securities | JMP Securities | Buy Maintains $41 → $45 | Buy | Maintains | $41 → $45 | +82.70% | Sep 8, 2025 |
Financial Forecast
Revenue This Year
11.36M
from 7.00M
Increased by 62.30%
Revenue Next Year
43.81M
from 11.36M
Increased by 285.58%
EPS This Year
-3.45
from -3.36
EPS Next Year
-3.36
from -3.45
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 29.6M | 183.2M | |||
Avg | 11.4M | 43.8M | |||
Low | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 323.0% | 1,512.4% | |||
Avg | 62.3% | 285.6% | |||
Low | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -3.15 | -2.52 | |||
Avg | -3.45 | -3.36 | |||
Low | -3.55 | -4.35 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | |||
Avg | - | - | |||
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.